https://www.selleckchem.com/products/erastin2.html
Introduction Psoriasis is a chronic inflammatory skin condition known to affect about 1%-3% of the global population. Psoriasis can be a serious burden to the patients, having deleterious effect on their physical, social and mental wellbeing. Systemic therapies consisting of methotrexate, cyclosporine, acitretin, PUVA, etc. used in moderate to severe psoriasis, are associated with end organ toxicity with long term use. Areas covered Role of Itolizumab, an anti CD6 biologic in regulation of lymphocyte development, selection, activation
Like
Comment
Share
